ACARBOSE Drug Patent Profile
✉ Email this page to a colleague
When do Acarbose patents expire, and what generic alternatives are available?
Acarbose is a drug marketed by Avet Lifesciences, Dash Pharms, Hangzhou Zhongmei, Hikma, Impax Labs, Somerset Theraps Llc, Strides Pharma, and Watson Labs. and is included in eight NDAs.
The generic ingredient in ACARBOSE is acarbose. There are six drug master file entries for this compound. Ten suppliers are listed for this compound. Additional details are available on the acarbose profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Acarbose
A generic version of ACARBOSE was approved as acarbose by HIKMA on May 7th, 2008.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for ACARBOSE?
- What are the global sales for ACARBOSE?
- What is Average Wholesale Price for ACARBOSE?
Summary for ACARBOSE
| US Patents: | 0 |
| Applicants: | 8 |
| NDAs: | 8 |
| Finished Product Suppliers / Packagers: | 9 |
| Raw Ingredient (Bulk) Api Vendors: | 80 |
| Clinical Trials: | 93 |
| Patent Applications: | 5,342 |
| Drug Prices: | Drug price information for ACARBOSE |
| What excipients (inactive ingredients) are in ACARBOSE? | ACARBOSE excipients list |
| DailyMed Link: | ACARBOSE at DailyMed |
Recent Clinical Trials for ACARBOSE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| CTC Clinical Trial Consultants AB | Phase 1 |
| Empros Pharma AB | Phase 1 |
| University of Zambia | Phase 3 |
Pharmacology for ACARBOSE
| Drug Class | alpha-Glucosidase Inhibitor |
| Mechanism of Action | alpha Glucosidase Inhibitors |
Medical Subject Heading (MeSH) Categories for ACARBOSE
Anatomical Therapeutic Chemical (ATC) Classes for ACARBOSE
US Patents and Regulatory Information for ACARBOSE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Avet Lifesciences | ACARBOSE | acarbose | TABLET;ORAL | 202271-001 | Feb 7, 2012 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Somerset Theraps Llc | ACARBOSE | acarbose | TABLET;ORAL | 091343-003 | Oct 17, 2013 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Watson Labs | ACARBOSE | acarbose | TABLET;ORAL | 077532-003 | May 7, 2008 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Hangzhou Zhongmei | ACARBOSE | acarbose | TABLET;ORAL | 213821-001 | Aug 18, 2020 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Dash Pharms | ACARBOSE | acarbose | TABLET;ORAL | 091053-001 | Jan 6, 2011 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
